Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor Agonists”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04964388
What this trial is testing

Effect of GLP-1 Receptor Agonists on Trabecular Bone Score

Who this might be right for
Osteoporosis, PostmenopausalDiabetes Mellitus, Type 2
University of Mississippi Medical Center 5
Post-approval studies (Phase 4)Study completedNCT05786521
What this trial is testing

Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults

Who this might be right for
AgingDiabetes Mellitus, Type 2PreDiabetes+1 more
The University of Texas Health Science Center at San Antonio 20
Not applicableStudy completedNCT05136287
What this trial is testing

SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.

Who this might be right for
Weight LossDiabetes Mellitus, Type 2Quality of Life+1 more
Jose Seijas Amigo 140
Testing effectiveness (Phase 2)WithdrawnNCT02472717
What this trial is testing

Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

Who this might be right for
Psoriatic ArthritisPsoriasisImpaired Glucose Tolerance+1 more
University Health Network, Toronto
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07319286
What this trial is testing

Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

Who this might be right for
Menstrual IrregularitiesType1 Diabetes MellitusGlucagon-Like Peptide-1 Receptor Agonists+1 more
Ain Shams University 50
Not applicableStudy completedNCT05535322
What this trial is testing

Real-world Evaluation of GLP-1 Receptor Agonists (GLP-1RA) on Efficacy and Persistence, Adherence and Therapeutic Inertia Among Type 2 Diabetes Adults With Obesity

Who this might be right for
Type 2 DiabetesObesity
Ana Palanca 26,944
Not applicableEnded earlyNCT06273163
What this trial is testing

Identifying Strategies to Curtail Weight Regain After GLP-1 Receptor Agonist Treatment Cessation

Who this might be right for
Obesity
University of Texas Southwestern Medical Center 39
Large-scale testing (Phase 3)Study completedNCT07820111
What this trial is testing

Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial

Who this might be right for
Obese DiabeticsObese Non Diabetic
Zagazig University 159
Large-scale testing (Phase 3)Study completedNCT02042664
What this trial is testing

Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics

Who this might be right for
ObesityDiabetes
Assistance Publique Hopitaux De Marseille 44
Testing effectiveness (Phase 2)Looking for participantsNCT07221214
What this trial is testing

GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

Who this might be right for
HIVAlcoholSmoking Cigarette+1 more
Vanderbilt University Medical Center 200
Not applicableNot Yet RecruitingNCT07817823
What this trial is testing

Yeast Protein Supplementation and Muscle Preservation During GLP-1RA-Induced Weight Loss

Who this might be right for
Overweight and Obesity in Adults Receiving GLP-1RA Treatment
Huazhong University of Science and Technology 200
Not applicableLooking for participantsNCT07213323
What this trial is testing

Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment

Who this might be right for
Obesity &Amp; OverweightDigestive Disorders
Hospices Civils de Lyon 50
Not applicableStudy completedNCT06236672
What this trial is testing

Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Type 2 DiabetesChronic Kidney Diseases
LMC Diabetes & Endocrinology Ltd. 348
Not applicableLooking for participantsNCT06734312
What this trial is testing

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

Who this might be right for
Obesity and Obesity-related Medical ConditionsObesity and OverweightObesity Prevention+3 more
Dr. Christopher McGowan 20
Not applicableLooking for participantsNCT07732738
What this trial is testing

Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.

Who this might be right for
Obesity
China-Japan Friendship Hospital 400
Post-approval studies (Phase 4)Not Yet RecruitingNCT07617155
What this trial is testing

GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis

Who this might be right for
Hypertriglyceridemia Induced Acute PancreatitisRecurrent Acute PancreatitisPancreatitis Relapsing+1 more
Peking Union Medical College Hospital 396
Early research (Phase 1)UnknownNCT06520540
What this trial is testing

HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects

Who this might be right for
Glucagon-Like Peptide-1 Receptor Agonists
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 72
Post-approval studies (Phase 4)Study completedNCT01744236
What this trial is testing

SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 70
Not applicableLooking for participantsNCT07229170
What this trial is testing

Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients

Who this might be right for
Obesity & OverweightTaste AlterationsWeight Loss+1 more
San Raffaele Telematic University 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07676331
What this trial is testing

Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

Who this might be right for
Hormone-receptor-positive Breast CancerEarly Breast Cancer
Universitaire Ziekenhuizen KU Leuven 168
Next Page